DANIEL LAEUPPLE: Open Payments
NPI 1669420865 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 28 payments from 10 companies in 2025. Trend: 2023 $1,347 · 2024 $1,247 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $149 |
| ABBVIE INC. | 5 | $113 |
| Axsome Therapeutics, Inc. | 5 | $86 |
| Almatica Pharma LLC | 4 | $74 |
| Corium, LLC | 2 | $32 |
| Alkermes, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, Auvelity, LOREEV XR, Azstarys, ARISTADA, SPRAVATO, Quviviq.
Industry payments across AL — which companies pay providers there.
